The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy
This study is to assess the efficacy and safety of palonosetron in preventing the acute and delayed emesis induced by 3-day highly emetogenic chemotherapy. A double-blind, crossover design is used and granisetron is the positive control.
Cancer
DRUG: Palonosetron|DRUG: Granisetron|DRUG: Dexamethasone|DRUG: Cisplatin
Complete Response(CR) within 24-120 hours after chemotherapy, 24-120 hours
CR within 0-120 hours after chemotherapy, 0-120 hours|CR within 0-24 hours after chemotherapy, 0-24 hours|Incidence of Adverse events, up to 3 months
This study is to assess the efficacy and safety of palonosetron in preventing the acute and delayed emesis induced by 3-day highly emetogenic chemotherapy. A double-blind, crossover design is used and granisetron is the positive control.